1Ito Y, Yoshida H, Nakano K, et al. BAG-1 expression in thyroid neoplasm: its correlation with Bcl-2 expression and carcinoma dedifferentiation[J]. Anticancer Res, 2003, 23(1B): 569-576.
2Takayama S, Sato T, Krajewski S, et al. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity [J]. Cell, 1995, 80(2): 279-284.
3Townsend PA, Cutress RI, Sharp A, et al. Bag-1: a multifunctional regulator of cell growth and survival[J]. Biochim Biophys Acta, 2003,1603(2): 83 -98.
4Schmidt U, Wochnik GM, Rosenhagen MC, et al. Essential role of the unusual DNA-binding motif of Bag-1 for inhibition of the glucocorticoid receptor[J]. J Biol Chem, 2003, 278 (7): 4926 - 4931.
6Alberti S, Esser C, Hohfeld J. BAG-1-a nucleotide exchange factor of Hsc70 with multiple cellular functions [J]. Cell Stress Chaperones,2003, 8(3): 225 -231.
7Takamura A, Adachi M, Wada I, et al. Accumulation of Hsp70/Hsc70 molecular chaperone regulator Bag-1 on COPI-coated structures in gastric epithelial cells[J]. Int J Oncol, 2003, 23(5): 1301 -1308.
8Xiong J, Chen J, Chernenko G, et al. Antisense Bag-1 sensitizes Hela cells to apoptosis by multiple pathways [J]. Biochem Biophys Res Commun, 2003, 312(3): 585 -591.
9O'Driscoll L, Linehan R, M Kennedy S, et al. Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag1, bax-alpha and MRP-1 mRNAs in breast cancer[J]. Cancer Left,2003, 201(2): 225 -236.
1Beerheide W,Tan YJ,Teng E,et al. Downregulation of proapoptotic proteins bax and bcl-X(S) in p53 overexpressing hepatocellular carcinomas[J]. Biochem Biophys Res Commun, 2000,273(1) : 54-61.
2Yang E,Zha T,Tockel J,et al. Bad,a heterodimeric partner for Bcl-XL and bcl-2 displaces bax and promotes cell death[J]. Cell, 1995,80(2): 285 -291.
3Vogellbaum MA, Tong TX, Higashiknbo R, et al. Transfection of C glioma cells with the bax gene and increased sensitivery to treamtment with cytosinoside[J].J Neurosurg, 1998,8(1) : 99-105.
4Hirotami M ,Zhang Y,Fujita N,et al. NH2-terminal BH4 domain of bel-2 is functional for heterodimerization with bax and inhibition of apoptosis [J] .J Biol Chem,1999,274(29) :20415-20420.
5Zemzami N ,Brenner C,Marzo I,et al. Subcelluar and submitochondrial mode of action of bcl-2-1ike oncoproteins [J]. Oncogene, 1998,16(17) :2265-2282.
6Rodriguez Feo JA, Fortes J,Aceituno E, et al.Doxazodin modifies bcl-2 and bax protsin express in the left ventricle of spontaneously hypertensive rats[J].J Hypertens,2000,18(3):307-315.
7Filippovich IV, Sorokina NI, Lisbona A, et al. Radiation-induced apoptosis in human myeloma cell line increases BCL-2/BAX dimmer formation and does not result in BAX/BAX homodimerization [J]. Int J Cancer,2001,92(5) :651-660.
8Muller W,Schneiders A,Hommel G, et al.Prognostic value of bcl-2 expression in gastric cancer [J]. Anticancer Res, 1998, 18(6B):4669-4704.
9Inada T,Kikuyama S, Ichikawa A, et al. bcl-2 expression as a prognostic factor of survival of gastric carcinoma [ J ]. Anticancer Res,1998,18(3B) :2003-2010.
10Aizawa K,Ueki K,Suzuki S,et al. Apoptosis and bcl-2 expression in gastric carcinomas:correlation withclinicopathological variables,p53 expression,cell proliferation and prognosis[J].Int J Oncol,1999,14(1):85-91.
